Cas:1000340-14-6 5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine manufacturer & supplier

Chemical Name:5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine

CAS.NO:1000340-14-6

Synonyms:5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine;3-Amino-5-chloro-6-methyl-7-azaindole;1H-Pyrrolo[2,3-b]pyridin-3-amine, 5-chloro-6-methyl-

Molecular Formula:C₈H₈ClN₃

Molecular Weight:181.622

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.4±0.1 g/cm3

Index of Refraction:1.738

PSA:54.70000

Exact Mass:181.040680

LogP:2.21

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrrolo[2,3-b]pyridin-3-amine, 5-chloro-6-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrrolo[2,3-b]pyridin-3-amine, 5-chloro-6-methyl- Use and application,5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine technical grade,usp/ep/jp grade.

Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine manufacturer Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated. 5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine supplier Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine vendor Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine factory The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.